<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39400521</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2045-7634</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cancer medicine</Title><ISOAbbreviation>Cancer Med</ISOAbbreviation></Journal><ArticleTitle>Empowering minoritized Alabamians screened for lung cancer-The Alabama Lung Cancer Awareness Screening and Education (ALCASE) project.</ArticleTitle><Pagination><StartPage>e70213</StartPage><MedlinePgn>e70213</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70213</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.70213</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Alabama only 4% of those eligible have been screened for lung cancer. The ALCASE project focused on navigating eligible individuals to lung cancer screening.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Trained local staff enrolled screen eligible individuals from seven rural counties and one urban county. Demographics and knowledge of and barriers to lung cancer screening were collected using questionnaires. Education was provided and individuals were navigated to undergo screening. Descriptive statistics for enrolled and screened participants were computed using SAS 9.4. Debriefing interviews were conducted with the ALCASE staff regarding facilitators/barriers to implementing this project and lessons learned. Using NVivo, themes were identified through a combined deductive and inductive process.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 447 people were contacted of which 257 were enrolled. Participants were predominantly African American (86.8%), female (56.8%), and 86.4% had health insurance. Study participants acknowledged the need for more education of lung cancer/screening procedures; help navigating clinics for screening services and having healthcare facilities close to home. The top five barriers to getting screened were transportation, financial issues, emotional concerns, healthcare insurance, and COVID-19. Of the 257, 106 participants (41%) completed a primary care referral and were screened for lung cancer. Debriefing interviews revealed: (i) Overall impressions of implementing ALCASE were positive. (ii) Barriers in implementing ALCASE were identified predominantly at the physician and institutional level. (iii) Facilitators in implementing ALCASE were identified at multiple levels. (iv) Suggestions on improving lung cancer screening leaned toward mitigating barriers at the institutional and structural level.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ability to get screened is severely challenged by both personal and structural barriers.</AbstractText><CopyrightInformation>© 2024 The Author(s). Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niranjan</LastName><ForeName>Soumya J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-9477-9187</Identifier><AffiliationInfo><Affiliation>Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tipre</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Claudia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowman</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baskin</LastName><ForeName>Monica L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Bristol Myers Squibb Foundation</Agency><Country /></Grant><Grant><Agency>Go2 for Lung Cancer</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Med</MedlineTA><NlmUniqueID>101595310</NlmUniqueID><ISSNLinking>2045-7634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000407" MajorTopicYN="N" Type="Geographic">Alabama</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Community Health Advisors</Keyword><Keyword MajorTopicYN="N">Equitable cancer screening</Keyword><Keyword MajorTopicYN="N">Lung cancer screening</Keyword></KeywordList><CoiStatement>No conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39400521</ArticleId><ArticleId IdType="pmc">PMC11472649</ArticleId><ArticleId IdType="doi">10.1002/cam4.70213</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7‐33.</Citation><ArticleIdList><ArticleId IdType="pubmed">35020204</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver AL. Lung cancer: epidemiology and screening. Surgical Clinics. 2022;102(3):335‐344.</Citation><ArticleIdList><ArticleId IdType="pubmed">35671760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2005. National Cancer Institute; 2008:2999.</Citation></Reference><Reference><Citation>Kerpel‐Fronius A, Tammemägi M, Cavic M, et al. Screening for lung cancer in individuals who never smoked: an international association for the study of lung cancer early detection and screening committee report. J Thorac Oncol. 2022;17(1):56‐66.</Citation><ArticleIdList><ArticleId IdType="pubmed">34455065</ArticleId></ArticleIdList></Reference><Reference><Citation>Henschke CI, Yankelevitz D, Libby D, Pasmantier M, Smith J, Miettinen O. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2008;359(8):871‐873.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065637</ArticleId></ArticleIdList></Reference><Reference><Citation>Team NLSTR . Reduced lung‐cancer mortality with low‐dose computed tomographic screening. N Engl J Med. 2011;365(5):395‐409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356534</ArticleId><ArticleId IdType="pubmed">21714641</ArticleId></ArticleIdList></Reference><Reference><Citation>US Preventive Services Task Force , Krist AH, Davidson KW, et al. Screening for lung cancer: US preventive services task Force recommendation statement. Ann Intern Med. 2014;160(5):330‐338.</Citation><ArticleIdList><ArticleId IdType="pubmed">24378917</ArticleId></ArticleIdList></Reference><Reference><Citation>Krist AH, Davidson KW, Mangione CM, et al. Screening for lung cancer: US preventive services task Force recommendation statement. JAMA. 2021;325(10):962‐970.</Citation><ArticleIdList><ArticleId IdType="pubmed">33687470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedewa SA, Kazerooni EA, Studts JL, et al. State variation in low‐dose computed tomography scanning for lung cancer screening in the United States. J Natl Cancer Inst. 2021;113(8):1044‐1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328984</ArticleId><ArticleId IdType="pubmed">33176362</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham D, Bhandari S, Pinkston C, Oechsli M, Kloecker G. Lung cancer screening registry reveals low‐dose CT screening remains heavily underutilized. Clin Lung Cancer. 2020;21(3):e206‐e211.</Citation><ArticleIdList><ArticleId IdType="pubmed">32001154</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge EE, Fouad MN, Hinton AW, et al. The Deep South network for cancer control: eliminating cancer disparities through community–academic collaboration. Fam Community Health. 2005;28(1):6‐19.</Citation><ArticleIdList><ArticleId IdType="pubmed">15625502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisovicz N, Johnson RE, Higginbotham J, et al. The deep south network for cancer control: building a community infrastructure to reduce cancer health disparities. Cancer. 2006;107(S8):1971‐1979.</Citation><ArticleIdList><ArticleId IdType="pubmed">16921494</ArticleId></ArticleIdList></Reference><Reference><Citation>Agriculture USDo . Rural‐Urban Commuting Area Codes. Accessed October 3, 2023.</Citation></Reference><Reference><Citation>Ahmed AM, Hardy CM, Bowman T, et al. Training and dissemination of lung cancer education curriculum among community health advisors in the deep south: a program evaluation. J Cancer Educ. 2022;1‐7:538‐544.</Citation><ArticleIdList><ArticleId IdType="pubmed">35254629</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan SJ, Durant RW, Wenzel JA, et al. Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ. 2019;34:26‐34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797508</ArticleId><ArticleId IdType="pubmed">28776305</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan SJ, Martin MY, Fouad MN, et al. Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials. Cancer. 2020;126(9):1958‐1968.</Citation><ArticleIdList><ArticleId IdType="pubmed">32147815</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan SJ, Wenzel JA, Martin MY, et al. Perceived institutional barriers among clinical and research professionals: minority participation in oncology clinical trials. JCO Oncol Pract. 2021;17(5):e666‐e675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257918</ArticleId><ArticleId IdType="pubmed">33974821</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates GR, Niranjan SJ, Ott C, et al. Adherence to pulmonary rehabilitation in COPD: a qualitative exploration of patient perspectives on barriers and facilitators. J Cardiopulm Rehabil Prev. 2019;39(5):344‐349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715533</ArticleId><ArticleId IdType="pubmed">31348127</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates G, Niranjan S, Brown G, et al. “ I eat chocolate Milk for dinner because we just have nothing in our fridge”: the invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States. A94 Advances in Health Services Research Focused on Interstitial Lung Disease and Cystic Fibrosis. American Thoracic Society; 2023:A2488.</Citation><ArticleIdList><ArticleId IdType="pubmed">39041893</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates G, Niranjan S, Woods B, Coleman E, Geurs R, Ladores S. P383 “it was all tailored around me”: qualitative evaluation of clinical effort against smoke exposure in cystic fibrosis (CEASE‐CF). J Cyst Fibros. 2023;22:S181.</Citation></Reference><Reference><Citation>Azungah T. Qualitative research: deductive and inductive approaches to data analysis. Qual Res J. 2018;18(4):383‐400.</Citation></Reference><Reference><Citation>Hou S‐I, Roberson K. A systematic review on US‐based community health navigator (CHN) interventions for cancer screening promotion—comparing community‐versus clinic‐based navigator models. J Cancer Educ. 2015;30:173‐186.</Citation><ArticleIdList><ArticleId IdType="pubmed">25219543</ArticleId></ArticleIdList></Reference><Reference><Citation>Roland KB, Milliken EL, Rohan EA, et al. Use of community health workers and patient navigators to improve cancer outcomes among patients served by federally qualified health centers: a systematic literature review. Health Equity. 2017;1(1):61‐76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5586005</ArticleId><ArticleId IdType="pubmed">28905047</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M, Kraschnewski J, Nishikawa B, et al. Outcomes of community health worker interventions. Evid Rep Technol Assess. 2009;181:1‐144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781407</ArticleId><ArticleId IdType="pubmed">20804230</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan SJ, Hardy C, Bowman T, et al. Rural cancer health during the COVID‐19 pandemic. J Cancer Educ. 2020;35:862‐863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455094</ArticleId><ArticleId IdType="pubmed">32860181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin NM, McWilliams A, Marshall HM. Lung cancer screening implementation: complexities and priorities. Respirology. 2020;25:5‐23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33200529</ArticleId></ArticleIdList></Reference><Reference><Citation>Niranjan SJ, Opoku‐Agyeman W, Carroll NW, et al. Distribution and geographic accessibility of lung cancer screening centers in the United States. Ann Am Thorac Soc. 2021;18(9):1577‐1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8663474</ArticleId><ArticleId IdType="pubmed">33784236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ersek JL, Eberth JM, McDonnell KK, et al. Knowledge of, attitudes toward, and use of low‐dose computed tomography for lung cancer screening among family physicians. Cancer. 2016;122(15):2324‐2331.</Citation><ArticleIdList><ArticleId IdType="pubmed">27294476</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll NM, Burnett‐Hartman AN, Joyce CA, et al. Real‐world clinical implementation of lung cancer screening—evaluating processes to improve screening guidelines‐concordance. J Gen Intern Med. 2020;35:1143‐1152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174472</ArticleId><ArticleId IdType="pubmed">31974902</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberth JM, McDonnell KK, Sercy E, et al. A national survey of primary care physicians: perceptions and practices of low‐dose CT lung cancer screening. Prev Med Rep. 2018;11:93‐99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030390</ArticleId><ArticleId IdType="pubmed">29984145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kota KJ, Ji S, Bover‐Manderski MT, Delnevo CD, Steinberg MB. Lung cancer screening knowledge and perceived barriers among physicians in the United States. JTO Clin Res Rep. 2022;3(7):100331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9234709</ArticleId><ArticleId IdType="pubmed">35769389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G, Hill LP, Schroeder MC, Kraus SJ, El‐Abiad KMB, Hoffman RM. Adherence to annual lung cancer screening in a centralized academic program. Clin Lung Cancer. 2024;25(1):e18‐e25.</Citation><ArticleIdList><ArticleId IdType="pubmed">37925362</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez ER, Triplette M. Addressing lung cancer screening disparities: what does it mean to Be centralized? Addressing Lung Cancer Screening Disparities: What Does it Mean to Be Centralized? Vol 19. American Thoracic Society; 2022:1457‐1458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9447398</ArticleId><ArticleId IdType="pubmed">36048121</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith HB, Ward R, Frazier C, Angotti J, Tanner NT. Guideline‐recommended lung cancer screening adherence is superior with a centralized approach. Chest. 2022;161(3):818‐825.</Citation><ArticleIdList><ArticleId IdType="pubmed">34536385</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuber J, Galea S, Link BG. Stigma and smoking: the consequences of our good intentions. Soc Serv Rev. 2009;83(4):585‐609.</Citation></Reference><Reference><Citation>Stuber J, Galea S. Who conceals their smoking status from their health care provider? Nicotine Tob Res. 2009;11(3):303‐307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2666372</ArticleId><ArticleId IdType="pubmed">19246431</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan MM, Oke S, Ellison D, Huard C, Veluz‐Wilkins A. Addressing tobacco use in underserved communities outside of primary care: the need to tailor tobacco cessation training for community health workers. Int J Environ Res Public Health. 2023;20(8):5574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10138947</ArticleId><ArticleId IdType="pubmed">37107861</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan NP, Castañeda H, Nichter M, et al. Lay health influencers: how they tailor brief tobacco cessation interventions. Health Educ Behav. 2012;39(5):544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096341</ArticleId><ArticleId IdType="pubmed">21986244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamann HA, Ver Hoeve ES, Carter‐Harris L, Studts JL, Ostroff JS. Multilevel opportunities to address lung cancer stigma across the cancer control continuum. J Thorac Oncol. 2018;13(8):1062‐1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417494</ArticleId><ArticleId IdType="pubmed">29800746</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph AM, Rothman AJ, Almirall D, et al. Lung cancer screening and smoking cessation clinical trials. SCALE (smoking cessation within the context of lung cancer screening) collaboration. Am J Respir Crit Care Med. 2018;197(2):172‐182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5768904</ArticleId><ArticleId IdType="pubmed">28977754</ArticleId></ArticleIdList></Reference><Reference><Citation>Schütte S, Dietrich D, Montet X, Flahault A. Participation in lung cancer screening programs: are there gender and social differences? A Systematic Review. Public Health Rev. 2018;39(1):1‐12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092821</ArticleId><ArticleId IdType="pubmed">30128168</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesthalter YB, Koppelman E, Bolton R, et al. Evaluations of implementation at early‐adopting lung cancer screening programs: lessons learned. Chest. 2017;152(1):70‐80.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223153</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>